J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine-January 2024-www.financetom.com

J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine

Jul 8, 2024 2:45 PM

July 8 (Reuters) - Emergent BioSolutions ( EBS ) said on

Monday Johnson & Johnson has agreed to pay $50 million

to settle claims related to a terminated manufacturing deal for

the latter's COVID-19 vaccine.

Previous page： TikTok: The app that makes social media double the fun Next page： France to slap Apple, Google with new digital tax in 2019

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TikTok: The app that makes social media double the fun

Dec 14, 2018

TikTok, the app that makes social media double the fun.

France to slap Apple, Google with new digital tax in 2019

Dec 18, 2018

With efforts to reform a European Union tax law not bringing the desired results, France is going to introduce from...

Netflix vs Amazon Prime: Personalisation vs content delivery?

Dec 14, 2018

Amazon Prime Video and Netflix are pulling no punches to ensure they are a few paces ahead of each other in the digital content game.

Apple makes software changes to avoid iPhone ban in China

Dec 20, 2018

A Chinese court had earlier banned the sale and import of most iPhone models after granting Qualcomm an injunction against Apple.